Shares of Medtronic are up $2.67, or 3%, to $86.15 in afternoon trading after the FDA announced it has approved the MiniMed 780G System for modifications to the SmartGuard Technology and for expanding the indications for use to include the Guardian 4 Sensor.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MDT:
- Piper wonders if Medtronic’s 780G will be delayed further by FDA inspections
- Medtronic price target lowered to $88 from $90 at Truist
- Starbucks appoints Brad Lerman as general counsel
- Citi opens two positive, one negative catalyst watches in medical technology
- Medtronic, DaVita announce launch Mozarc Medical